Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Remedy Taking a hit why? -- Ignore unavailable to you. Want to Upgrade?

To: seth thomas who wrote (524)	4/20/1998 5:29:00 PM
From: Shege Dambanza	Respond to of 763

I think our messages got interleaved. See my post # 525. The other thing Remedy should do (and by some accounts are already doing) is to develop more solutions on top of their AR platform. A la Baystone. Solutions coming from Remedy instead of a partner will probably have a little more cachet. The flat fee rollout they announced today is also a good idea.

To: seth thomas who wrote (524)	4/20/1998 5:29:00 PM
From: wrm1	Read Replies (1) \| Respond to of 763

The interest income was higher than Q4 or the average of all quarters in 97', but this was in the projections for the 6 cents profit. Their announcement regarding a downtrend for Q1 took this into account, I thought, and the additional new business looks as though the net income outside of interest income looked good from a growth standpoint. Maybe I'm too optimistic?